| Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer. | |
| | |
MedLine Citation:
|
PMID: 23340905 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: Higher plasma pyridoxal 5'-phosphate (PLP) levels are associated with a decreased incidence of colorectal cancer, but the influence of plasma PLP on survival of patients with colorectal cancer is unknown. We prospectively examined whether prediagnostic plasma PLP levels are associated with mortality among colorectal cancer patients. METHODS: We included 472 incident cases of colorectal cancer identified in the Nurses' Health Study, the Health Professionals Follow-up Study, and the Physicians' Health Study from 1984 to 2002. The patients provided blood samples two or more years before cancer diagnosis. Stratified Cox proportional hazards models were used to calculate hazard ratios (HR) with 95 % confidence intervals (CI) adjusted for other risk factors for cancer survival. RESULTS: Higher plasma PLP levels were not associated with a significant reduction in colorectal cancer-specific (169 deaths) or overall mortality (259 deaths). Compared with patients who had less than 45 pmol/ml of plasma PLP (median: 33.6 pmol/ml), those who had 110 pmol/ml or higher levels (median: 158.8 pmol/ml) had multivariable HRs of 0.85 (95 % CI 0.50-1.45, p trend = 0.37) and 0.87 (95 % CI 0.56-1.35, p trend = 0.24) for colorectal cancer-specific and overall mortality. Higher plasma PLP levels, however, seemed to be associated with better survival among patients who had lower circulating 25-hydroxyvitamin D(3) levels (<26.5 ng/ml) (p interaction ≤.005). CONCLUSIONS: Higher prediagnostic plasma PLP levels were not associated with an improvement on colorectal cancer survival overall. Further research is needed to clarify the influence of vitamin B6 on colorectal cancer progression and survival. |
| | |
Authors:
|
Youjin Je; Jung Eun Lee; Jing Ma; Xuehong Zhang; Eunyoung Cho; Bernard Rosner; Jacob Selhub; Charles S Fuchs; Jeffrey Meyerhardt; Edward Giovannucci |
Related Documents
:
|
11350725 - The management of ductal carcinoma in situ of the breast. 17323695 - Modeling the effects of biologically incorporated radionuclides and chronic low-dose io... 1962255 - The adequacy of current occupational standards for protecting the health of nuclear wor... 8244825 - Pre-installation empirical testing of room shielding for high dose rate remote afterloa... 2382975 - Interrelation between western type cancers and non-western type cancers as regards thei... 23205225 - The prognostic role of p16 expression in tonsil cancer treated by either surgery or rad... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-23 |
Journal Detail:
|
Title: Cancer causes & control : CCC Volume: - ISSN: 1573-7225 ISO Abbreviation: Cancer Causes Control Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9100846 Medline TA: Cancer Causes Control Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Food and Nutrition, Kyung Hee University, Seoul, Korea, youjinje@khu.ac.kr. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Shape selective plate-form Ga(2)O(3) with strong metal-support interaction to overlying Pd for hydro...
Next Document: Enhanced separation of colloidal particles in an AsPFF device with a tilted sidewall and vertical fo...